Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE
Authors
Keywords
Juvenile-onset systemic lupus erythematosus, Cardiovascular disease, Lipids, CD8+ T cells, Interferon
Journal
EBioMedicine
Volume -, Issue -, Pages 103243
Publisher
Elsevier BV
Online
2021-02-24
DOI
10.1016/j.ebiom.2021.103243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
- (2019) Eeva Sliz et al. CIRCULATION
- New therapies for systemic lupus erythematosus — past imperfect, future tense
- (2019) Grainne Murphy et al. Nature Reviews Rheumatology
- Single-cell immune landscape of human atherosclerotic plaques
- (2019) Dawn M. Fernandez et al. NATURE MEDICINE
- Data-driven multivariate population subgrouping via lipoprotein phenotypes versus apolipoprotein B in the risk assessment of coronary heart disease
- (2019) Pauli Ohukainen et al. ATHEROSCLEROSIS
- Type-I interferons in atherosclerosis
- (2019) Hung-Jen Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting interferons and their pathways in systemic lupus erythematosus
- (2018) François Chasset et al. AUTOIMMUNITY REVIEWS
- Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine AtherosclerosisNovelty and Significance
- (2018) Clément Cochain et al. CIRCULATION RESEARCH
- Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
- (2018) Michael V. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- CD8+ T-cells contribute to lesion stabilization in advanced atherosclerosis by limiting macrophage content and CD4+ T-cell responses
- (2018) Janine van Duijn et al. CARDIOVASCULAR RESEARCH
- Monocyte-Macrophages and T Cells in Atherosclerosis
- (2017) Ira Tabas et al. IMMUNITY
- Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype
- (2017) Veronika Sanin et al. Current Cardiology Reports
- Protective and pathogenic roles of CD8+ T cells in atherosclerosis
- (2016) Clement Cochain et al. BASIC RESEARCH IN CARDIOLOGY
- Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality RiskNovelty and Significance
- (2016) Patrick R. Lawler et al. CIRCULATION RESEARCH
- The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses
- (2016) Katarzyna Blaszczyk et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Why, why, why de-lupus (does so badly in clinical trials)
- (2016) David A Isenberg et al. Expert Review of Clinical Immunology
- The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis
- (2016) Diana S. Novikova et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
- (2016) Peter Würtz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus
- (2016) X Feng et al. LUPUS
- Differences in disease phenotype and severity in SLE across age groups
- (2016) N Ambrose et al. LUPUS
- Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA
- (2016) Johannes Kettunen et al. Nature Communications
- Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
- (2016) Malgorzata Szelag et al. Oncotarget
- Remission in SLE: closing in on the target
- (2015) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
- (2015) Kate Franklyn et al. ANNALS OF THE RHEUMATIC DISEASES
- Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study
- (2015) Hsin-Hui Yu et al. ATHEROSCLEROSIS
- ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
- (2015) Tauno Metsalu et al. NUCLEIC ACIDS RESEARCH
- The vascular phenotype of children with systemic lupus erythematosus
- (2015) Catherine Quinlan et al. PEDIATRIC NEPHROLOGY
- Lipid profile among girls with systemic lupus erythematosus
- (2015) Daniele Machado et al. RHEUMATOLOGY INTERNATIONAL
- Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment
- (2014) Patricia Ruiz-Limon et al. ANNALS OF THE RHEUMATIC DISEASES
- Apolipoprotein B as an independent predictor of arterial stiffness in systemic lupus erythematosus patients
- (2014) Jirateep Kwankaew et al. International Journal of Rheumatic Diseases
- Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein
- (2013) Stacy P Ardoin et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiovascular disease in lupus
- (2013) Jason S. Knight et al. CURRENT OPINION IN RHEUMATOLOGY
- Association between habitual dietary intake and lipoprotein subclass profile in healthy young adults
- (2013) L.H. Bogl et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect
- (2012) E Cairoli et al. LUPUS
- Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study
- (2012) John A. Morrison et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients
- (2012) Emily C. Somers et al. PLoS One
- Use of atorvastatin in systemic lupus erythematosus in children and adolescents
- (2011) L. E. Schanberg et al. ARTHRITIS AND RHEUMATISM
- The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
- (2011) C.-S. Yee et al. RHEUMATOLOGY
- The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus
- (2011) J Michelle Kahlenberg et al. ARTHRITIS RESEARCH & THERAPY
- Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus
- (2010) Aimee O. Hersh et al. ARTHRITIS CARE & RESEARCH
- Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus
- (2009) Maureen McMahon et al. ARTHRITIS AND RHEUMATISM
- Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort
- (2009) Laura E. Schanberg et al. ARTHRITIS AND RHEUMATISM
- Interferon gamma: A master regulator of atherosclerosis
- (2008) James E. McLaren et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Childhood Levels of Serum Apolipoproteins B and A-I Predict Carotid Intima-Media Thickness and Brachial Endothelial Function in Adulthood
- (2008) Markus Juonala et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
- (2008) Matthew J McQueen et al. LANCET
- ApoB/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol
- (2007) C. Schmidt et al. ATHEROSCLEROSIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started